Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
07:22:06 EDT Mon 06 Oct 2025
Enter Symbol
or Name
USA
CA



Z:NBY - NOVABAY PHARMACEUTICALS INC - https://investors.novabay.com/
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
NBY - Z8.21.38·1.610.11.360.401    4.44  0.4607:01:48Aug 1415 min RT 2¢

Recent Trades - All 1 today
Time ETExPriceChangeVolume
07:01:48Z1.380.0277
07:00:00Z1.380.0235
06:43:54Z1.380.026
     
     
     
     
     
     
     

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2025-08-14 17:12U:NBYSEDAR Interim Financial StatementsSEDAR Interim MD & A
2025-05-15 14:19U:NBYSEDAR Interim Financial StatementsSEDAR Interim MD & A
2025-04-04 20:36U:NBYSEDAR Audited Annual Financial StatementsSEDAR MD & A
2025-04-04 20:31U:NBYSEDAR Annual Information FormSEDAR Annual Information Form
2025-03-07 06:50U:NBYNews ReleaseNovaBay Pharmaceuticals to Hold Special Meeting of Stockholders
2025-01-23 08:00U:NBYNews ReleaseNovaBay Pharmaceuticals Completes the Sale of its Eyecare Business to PRN and Further Adjourns its Special Meeting of Stockholders on Dissolution Proposal
2024-12-19 06:50U:NBYNews ReleaseNovaBay Pharmaceuticals Announces the Further Adjournment of the Special Meeting of Stockholders
2024-12-09 06:50U:NBYNews ReleaseNovaBay CEO Letter to Stockholders Urges a FOR Vote at Upcoming Reconvened Special Meeting
2024-11-22 16:05U:NBYNews ReleaseNovaBay Pharmaceuticals to Reconvene Special Meeting of Stockholders on December 18, 2024
2024-11-15 08:00U:NBYNews ReleaseProminent Independent Proxy Advisory Firm ISS Supports NovaBay Pharmaceuticals' Proposals to Authorize the Sale of its Avenova Brand
2024-11-07 17:04U:NBYSEDAR Interim Financial StatementsSEDAR Interim MD & A
2024-11-07 16:05U:NBYNews ReleaseNovaBay Pharmaceuticals Reports Third Quarter 2024 Financial Results
2024-11-06 16:05U:NBYNews ReleaseNovaBay Pharmaceuticals Accepts Revised Offer from PRN Physician Recommended Nutriceuticals, LLC and Enters into an Amendment to the Asset Purchase Agreement to Increase Purchase Price
2024-10-29 08:00U:NBYNews ReleaseNovaBay Pharmaceuticals Board Determines Unsolicited Offer is Superior to Asset Purchase Agreement with PRN Physician Recommended Nutriceuticals, LLC